SCHEMBL7105196

SCHEMBL7105196

O=C(CS)Nc1ccc(-c2nc3ccccc3o2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.70
▸ RAB9A P51151 5/20 0.70
▸ HSD17B10 Q99714 5/20 0.66
▸ MEN1 O00255 4/20 0.66
▸ KMT2A Q03164 4/20 0.66
▸ THRB P10828 1/20 0.66
▸ ALOX15 P16050 1/20 0.66
▸ MAPT P10636 8/20 0.64
▸ SMN1; SMN2 Q16637 6/20 0.64
▸ KDM4E B2RXH2 6/20 0.64
▸ ALDH1A1 P00352 5/20 0.64
▸ HPGD P15428 4/20 0.64
▸ RXFP1 Q9HBX9 3/20 0.64
▸ PPARG P37231 1/20 0.64
▸ NCOA2 Q15596 1/20 0.64
▸ NCOA1 Q15788 1/20 0.64
▸ CEPT1 Q9Y6K0 1/20 0.64
▸ TP53 P04637 3/20 0.62
▸ TNKS O95271 1/20 0.62
▸ BCHE P06276 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7105775 0.87 NPC1 (0.70) NPC1RAB9AHSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL7109169 0.86 NPC1 (0.68) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL15702608 0.85 SMN1; SMN2 (0.71) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL15702631 0.84 NPC1 (0.73) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL2247579 0.82 RAB9A (1.00) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL2243410 0.79 KDM4E (0.76) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL4370566 0.78 CHIA (0.77) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL24155564 0.77 NPC1 (0.67) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL31170 0.76 NPC1 (0.81) NPC1RAB9AHSD17B10MEN1KMT2A
SCHEMBL25318603 0.75 UTRN (0.63) NPC1RAB9AHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812319-B9 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2003-10-08 — — EP claimed
EP-0812319-B1 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2002-07-10 — — EP claimed
US-6034246-A ANTICANCER AGENT CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2000-03-07 — — US claimed
EP-0812319-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1997-12-17 — — EP claimed
WO-1996026932-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-09-06 — — WO claimed
EP-0812319-B9 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2003-10-08 — — EP disclosed
EP-0812319-B1 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2002-07-10 — — EP disclosed
US-6034246-A ANTICANCER AGENT CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2000-03-07 — — US disclosed
WO-1996026932-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-09-06 — — WO disclosed
Send feedback